No heart risk from hormones taken near menopause | Science News

SUPPORT SCIENCE NEWS

Science News is a nonprofit.

Help us keep you informed.


News

No heart risk from hormones taken near menopause

By
2:35pm, April 24, 2007

Contrary to some earlier indications, hormone replacement therapy might not impart heart risks to women who take it during their 50s.

Studies over the past 2 decades have produced mixed findings on whether estrogen—alone or in combination with progestin—is good, bad, or neutral for postmenopausal women who take it to ward off hot flashes and night sweats (SN: 4/15/06, p. 228: Available to subscribers at Estrogen Safety: Studies raise cancer, blood clot questions; 5/31/03, p. 341: Available to subscribers at Flawed Therapy: Hormone replacement takes more hits).

To gauge the risks of various ailments from hormone therapy, Jacques E. Rossouw of the National Heart, Lung and Blood Institute in Bethesda, Md., and his colleagues combined data from two trials that included more than 27,000 women. Those who had had hysterectomies got estrogen or a placebo, while those who hadn't got an estrogen-progestin combination

This article is only available to Science News subscribers. Already a subscriber? Log in now. Or subscribe today for full access.

Get Science News headlines by e-mail.

More Body & Brain articles

From the Nature Index Paid Content